Modulation of synaptic maintenance
US-2015368324-A1 · Dec 24, 2015 · US
US2018024117A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018024117-A1 |
| Application number | US-201715648293-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jul 12, 2017 |
| Priority date | Jul 12, 2016 |
| Publication date | Jan 25, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compositions, devices and methods are described for improving adhesion, attachment, and/or differentiation of cells in a microfluidic device or chip. In one embodiment, one or more ECM proteins are covalently coupled to the surface of a microchannel of a microfluidic device. The microfluidic devices can be stored or used immediately for culture and/or support of living cells such as mammalian cells, and/or for simulating a function of a tissue, e.g., a liver tissue, muscle tissue, etc. Extended adhesion and viability with sustained function over time is observed.
Opening claim text (preview).
We claim: 1 . A method of treating a microfluidic device, comprising: a) providing a microfluidic device comprising a microchannel comprising a surface, said microchannel in fluidic communication with a fluid source comprising fluid; b) covalently attaching one or more proteins or peptides to said microchannel surface so as to create a treated surface; and c) storing said microfluidic device. 2 . The method of claim 1 , wherein said storing is done at a controlled temperature below room temperature. 3 . The method of claim 1 , wherein said storing is done at between 2 and 10° C. 4 . The method of claim 1 , wherein said one or more covalently attached proteins is collagen I. 5 . The method of claim 4 , wherein said covalently attached collagen I is stored dry. 6 . The method of claim 1 , wherein said one or more covalently attached proteins is laminin. 7 . The method of claim 6 , wherein said covalently attached laminin is stored wet. 8 . The method of claim 1 , wherein said method further comprises: d) seeding viable cells on said treated surface so as to create attached cells; e) flowing fluid from said fluid source through said microchannel so as to create flowing conditions; and f) culturing said attached cells under said flow conditions such that said cells remain attached and viable for at least 14 days. 9 . The method of claim 8 , wherein said cells are hepatocytes. 10 . The method of claim 1 , wherein said microchannel surface is PDMS and is plasma treated prior to step b). 11 . A method of culturing cells, comprising: a) providing a microfluidic device comprising a microchannel comprising a surface, said microchannel in fluidic communication with a fluid source comprising fluid; b) covalently attaching a bifunctional crosslinker to said surface to create attached crosslinker, c) covalently attaching one or more proteins or peptides to said attached crosslinker as to create a treated surface; d) seeding viable cells on said treated surface so as to create attached cells; e) flowing fluid from said fluid source through said microchannel so as to create flowing conditions; and f) culturing said attached cells under said flow conditions such that said cells remain attached and viable for at least 7 days. 12 . The method of claim 11 , wherein said surface is a membrane and said membrane is micropatterned. 13 . The method of claim 11 , wherein said cells are skeletal muscle cells that align with said micropattern. 14 . The method of claim 11 , wherein said crosslinker is activated with UV light in the presence of a mask. 15 . A kit comprising: a) a microfluidic device comprising a surface; b) a crosslinker comprising at least one light-reactive portion, and at least one chemically reactive portion; c) at least one protein or peptide; and d) a set of instructions. 16 . The kit of claim 15 , further comprising cells.
Cross-linking · CPC title
Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts · CPC title
for testing toxicity · CPC title
Synthetic polymers · CPC title
on intercellular interactions · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.